Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis
暂无分享,去创建一个
[1] J. Douketis,et al. Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin , 2004, Circulation.
[2] J. Douketis,et al. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. , 2004, Archives of internal medicine.
[3] D. Blacker,et al. Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy , 2003, Neurology.
[4] A. Turpie,et al. Perioperative management of patients receiving oral anticoagulants: a systematic review. , 2003, Archives of internal medicine.
[5] Martha J. Radford,et al. Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .
[6] L. Kalra,et al. Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice? , 2001, Archives of internal medicine.
[7] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[8] T O Tengs,et al. Health-related quality of life after stroke a comprehensive review. , 2001, Stroke.
[9] R. McLeod,et al. Subcutaneous Heparin Versus Low-Molecular-Weight Heparin as Thromboprophylaxis in Patients Undergoing Colorectal Surgery: Results of the Canadian Colorectal DVT Prophylaxis Trial: A Randomized, Double-Blind Trial , 2001, Annals of surgery.
[10] S. Port. Systolic blood pressure and mortality , 2000, The Lancet.
[11] C. Francis,et al. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients : A double-blind, randomized comparison , 2000 .
[12] B. Gage,et al. Effect and outcomes of the ASGE guidelines on the periendoscopic management of patients who take anticoagulants. , 2000 .
[13] B. Morrey,et al. Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement , 2000, Annals of Internal Medicine.
[14] F. Morady,et al. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation. , 2000, Journal of the American College of Cardiology.
[15] W M O'Fallon,et al. Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. , 2000, Stroke.
[16] S. Clark,et al. Effect of low molecular weight heparin (fragmin) on bleeding after cardiac surgery. , 2000, The Annals of thoracic surgery.
[17] S. Takagi,et al. Relationship between blood pressure level and mortality rate: an 18‐year study conducted in two rural communities in Japan , 2000, Journal of hypertension.
[18] R. Hiebert,et al. Anticoagulant Treatment of Thromboembolism with Intravenous Heparin Therapy in the Early Postoperative Period Following Total Joint Arthroplasty* , 2000, The Journal of bone and joint surgery. American volume.
[19] J. Douketis,et al. Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. , 1999, Chest.
[20] O. Benavente,et al. Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 1999, Annals of Internal Medicine.
[21] G. Raskob,et al. Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. , 1999, Archives of internal medicine.
[22] K. Carter,et al. Phacoemulsification and lens implantation in patients treated with aspirin or warfarin , 1998, Journal of cataract and refractive surgery.
[23] H. Spotnitz,et al. Outpatient Pacemaker Procedures in Orally Anticoagulated Patients , 1998, Pacing and clinical electrophysiology : PACE.
[24] M. Wahl. Dental surgery in anticoagulated patients. , 1998, Archives of internal medicine.
[25] David M. Smith,et al. Risk of major hemorrhage for outpatients treated with warfarin , 1998, Journal of General Internal Medicine.
[26] J. Hirsh,et al. Management of anticoagulation before and after elective surgery. , 1997, The New England journal of medicine.
[27] B. Gage,et al. The Effect of Stroke and Stroke Prophylaxis With Aspirin or Warfarin on Quality of Life , 1996 .
[28] Vittorio Pengo,et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) , 1996, The Lancet.
[29] M. McDonell,et al. Management and Prognosis of Life-threatening Bleeding During Warfarin Therapy , 1996 .
[30] S. Fihn,et al. The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin , 1996, Annals of Internal Medicine.
[31] C. Legnani,et al. Warfarin Withdrawal , 1996, Clinical pharmacokinetics.
[32] Gordon B. Hazen,et al. A Cost-effectiveness Analysis of Total Hip Arthroplasty for Osteoarthritis of the Hip , 1996 .
[33] C. Otley,et al. Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs. , 1996, Archives of dermatology.
[34] A. Haeberli,et al. Rebound after cessation of oral anticoagulant therapy: the biochemical evidence , 1996, British journal of haematology.
[35] B. Gersh,et al. Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota. , 1995, Mayo Clinic proceedings.
[36] J. Vandenbroucke,et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. , 1995, The New England journal of medicine.
[37] A S Detsky,et al. Users' guides to the medical literature. VII. How to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? Evidence Based Medicine Working Group. , 1995, JAMA.
[38] C. Colwell,et al. Prevention of venous thromboembolism. , 1994, Chest.
[39] Stroke Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study , 1994, The Lancet.
[40] F. R. Rosendaal,et al. Thromboembolic and Bleeding Complications in Patients With Mechanical Heart Valve Prostheses , 1994, Circulation.
[41] R. Beyth,et al. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. , 1993, The American journal of medicine.
[42] W G Henderson,et al. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. , 1993, The New England journal of medicine.
[43] V. Kakkar,et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery , 1993, The Lancet.
[44] J. Clausen,et al. Blood pressure and mortality: an epidemiological survey with 10 years follow-up. , 1992, Journal of human hypertension.
[45] M. Blombäck,et al. Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients. , 1991, European heart journal.
[46] C. Roberts,et al. Cataract surgery in anticoagulated patients , 1991, Journal of cataract and refractive surgery.
[47] F. Crawford,et al. Long-term results of aortic valve replacement. , 1991, Cardiology clinics.
[48] S. Goldhaber,et al. Complications of heparin therapy after total joint arthroplasty. , 1990, The Journal of bone and joint surgery. American volume.
[49] G. A. Robinson,et al. Warfarin and cataract extraction. , 1989, The British journal of ophthalmology.
[50] D. Ilstrup,et al. Ocular surgery on patients receiving long-term warfarin therapy. , 1989, American journal of ophthalmology.
[51] L Goldman,et al. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. , 1989, The American journal of medicine.
[52] L. McMahan,et al. Anticoagulants and cataract surgery , 1988, Journal of cataract and refractive surgery.
[53] P. T. Onundarson,et al. Chronic atrial fibrillation--epidemiologic features and 14 year follow-up: a case control study. , 1987, European heart journal.
[54] J. Hirsh,et al. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. , 1986, The New England journal of medicine.
[55] C. Mok,et al. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial. , 1985, Circulation.
[56] J R Beck,et al. A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. , 1982, The American journal of medicine.
[57] G. Lawrie,et al. Clinical experience with the Smeloff-Cutter prosthesis: 1- to 12-year follow-up. , 1980, The Annals of thoracic surgery.
[58] E. Lefrak,et al. Aortic Valve Replacement: A Ten‐Year Follow‐up of Non‐Cloth‐Covered vs Cloth‐Covered Caged‐Ball Prosthesesm , 1977, Circulation.
[59] J. Criley,et al. Presystolic murmur in atrial fibrillation. , 1977, Circulation.
[60] W. Stanford,et al. Thromboembolic phenomena in patients with prosthetic aortic valves who did not receive anticoagulants. , 1977, The Annals of thoracic surgery.
[61] L. Poller,et al. EVIDENCE FOR "REBOUND" HYPERCOAGULABILITY AFTER STOPPING ANTICOAGULANTS. , 1964, Lancet.
[62] M. Prins,et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose infractionated heparin for venous thromboembolism [Cochrane review] , 2004 .
[63] J. Hirsh,et al. Managing oral anticoagulant therapy. , 2001, Chest.
[64] M. Cucherat,et al. Prevention of Venous Thromboembolism in Internal Medicine with Unfractionated or Low-molecular-weight Heparins: A Meta-analysis of Randomised Clinical Trials , 2000, Thrombosis and Haemostasis.
[65] M. Glanz,et al. The Sharer , 2000, Annals of Internal Medicine.
[66] D. Zahger. Use of Enoxaparin for the Chronically Anticoagulated Patient Before and After Procedures , 1999 .
[67] R. N. Anderson,et al. National Vital Statistics Reports , 1999 .
[68] M. Gould,et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. , 1999, Annals of internal medicine.
[69] J. Pawlak,et al. Prospective double-arm study of fibrinolysis in surgical patients. , 1998, The Journal of surgical research.
[70] F. Giubilei,et al. Long-term prognosis after a minor stroke: 10-year mortality and major stroke recurrence rates in a hospital-based cohort. , 1998, Stroke.
[71] J. Paramo,et al. Hemostatic markers in surgery: a different fibrinolyfic activity may be of pathophysiological significance in orthopedic versus abdominal surgery , 1997, International journal of clinical & laboratory research.
[72] A. Laupacis,et al. Prognosis of individuals with atrial fibrillation. , 1996, The Canadian journal of cardiology.
[73] J. Madura,et al. The management of patients on chronic Coumadin therapy undergoing subsequent surgical procedures. , 1994, The American surgeon.
[74] H. White,et al. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation : stroke prevention in atrial fibrillation II study. Commentary , 1994 .
[75] J. Vandenbroucke,et al. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. , 1993, Archives of internal medicine.
[76] Leandro Provinciali,et al. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .
[77] Jerome P. Kassirer,et al. A Convenient Approximation of Life Expectancy , 1992 .
[78] R. Collins,et al. Reduction in Fatal Pulmonary Embolism and Venous Thrombosis by Perioperative Administration of Subcutaneous Heparin: Overview of Results of Randomized Trials in General, Orthopedic, and Urologic Surgery , 1989 .
[79] R. Ling. Anticoagulants and cataract surgery. , 1988, Ophthalmic surgery.
[80] R. Bloch,et al. Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.